Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.

Nethanel AsherEdith M MaromGuy Ben-BetzalelErez Nissim BaruchYael Steinberg-SilmanJacob SchachterRonnie Shapira-FrommerGal Markel

Published in: The oncologist (2019)

This article sheds light on a poorly described immune-related adverse event: recurrent pneumonitis despite complete discontinuation of immunotherapy (unprovoked), in patients with advanced melanoma.

Keyphrases

venous thromboembolism
interstitial lung disease
systemic sclerosis
emergency department
newly diagnosed
adverse drug